During the N-glycosylation reaction, it has been shown that 'free' N-glycans are generated either from lipid-linked oligosaccharides or from misfolded glycoproteins. In both cases, occurrence of high mannose-type free glycans is well-documented, and the molecular mechanism for their catabolism in the cytosol has been studied. On the other hand, little, if anything, is known with regard to the accumulation of more processed, complex-type free oligosaccharides in the cytosol of mammalian cells. During the course of comprehensive analysis of N-glycans in cancer cell membrane fractions [Naka et al. (2006) J. Proteome Res. 5, 88-97], we found that a significant amount of unusual, complextype free N-glycans were accumulated in the stomach cancerderived cell lines, MKN7 and MKN45. The most abundant and characteristic glycan found in these cells was determined to be NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3Manβ1-4GlcNAc. Biochemical analyses indicated that those glycans found were cytosolic glycans derived from lysosomes due to low integrity of the lysosomal membrane. Since the accumulation of these free N-glycans was specific to only two cell lines among the various cancer cell lines examined, these cytosolic N-glycans may serve as a specific biomarker for diagnosis of specific tumours. A cytosolic sialidase, Neu2, was shown to be involved in the degradation of these sialoglycans, indicating that the cytosol of mammalian cells might be equipped for metabolism of complex-type glycans.
INTRODUCTION
It is known that the ER (endoplasmic reticulum) is the site for assembly of polypeptide chains destined for either secretion or routing into various subcellular compartments. N-glycosylation is one of the most common co-and post-translational modifications of eukaryotic proteins that occurs in the lumen of the ER. There is a growing amount of evidence that N-linked glycans play important roles in folding, and intra-and/or inter-cellular trafficking of Nglycosylated proteins [1] [2] [3] .
During N-glycosylation of proteins, a significant amount of free glycans are generated in the lumen of the ER by a mechanism yet to be clarified [4] . Free glycans are also formed in the cytosol through deglycosylation of misfolded glycoproteins, which are subjected to destruction by a cellular system called ERAD (ERassociated degradation), by the action of cytoplasmic PNGase (peptide N-glycanase) [5] . Free glycans formed in the ER or by the PNGase in the cytosol should bear di-N-acetylchitobiose (GlcNAcβ1-4GlcNAc) at their reducing termini, and are often called Gn2 species. However, most of the free glycans found in the cytosol have only a single GlcNAc at their reducing termini (Gn1 glycans). This conversion of Gn2 into Gn1 was predicted to be due to the action of the cytosolic ENGase (endo-β-Nacetylglucosaminidase) [6, 7] or chitobiase [8] . On the other hand, occurrence of free sialoglycans in normal animal cells has not been normally observed, with the exception of the case with mouse liver cytosol [9] . The rare occurrence of the 'Golgi' form (i.e. the complex-type glycan) was presumed to be the evidence that most, if not all, of the glycoproteins which are subjected to the ERAD indeed originated from the ER.
Recently we developed a method for rapid and comprehensive analysis of total N-glycans of membrane fractions of some cancer cells [10] and found that U937 cells (histiocytic lymphoma cells) expressed large amounts of glycans containing polylactosamine residues, and MKN45 cells (gastric adenocarcinoma cells) contained glycans containing multiple fucose residues. During the studies on the structural analysis of total glycans of cell membrane fractions, we found that various free glycans derived from Nglycans were accumulated in some cancer cells. Most notably, MKN7 and MKN45 cells contained characteristic free glycans derived from complex-type glycans.
In the present paper, we carried out quantitative analysis of the free glycans in various cancer-derived cell lines. Surprisingly, a large amount of free sialoglycans were found to be accumulated in MKN7 and MKN45 cells, both of which are derived from stomach cancer. Examination of the subcellular localization of organelle-marker enzymes clearly indicated that MKN45 cells have a relatively leaky lysosomal membrane, and a significant amount of lysosomal enzymes were found in the cytosol. This result led us to hypothesize that loss of integrity of lysosomal membrane caused the inefficient degradation of free N-glycans in the lysosomes, as well as the leakage of lysosomal components Abbreviations used: 2AA, 2-aminobenzoic acid; CAE, capillary affinity electrophoresis; DHB, 2,5-dihydroxybenzoic acid; ER, endoplasmic reticulum; ERAD, ER-associated degradation; Lamp, lysosome-associated membrane protein; LDH, lactate dehydrogenase; MALDI-TOF, matrix-assisted laserdesorption ionization-time-of-flight; MAM, Maackia amurensis lectin; MS/MS, tandem MS; 4MU-NeuAc, 4-methylumbelliferyl NeuAc; ORF, open reading frame; RT, reverse transcriptase; PHA-E4, Phaseolus vulgalis agglutinin; PNGase, peptide N-glycanase; RSL, Rhizopus stolonifer lectin; SSA, Sambucus sieboldiana lectin. 1 Correspondence may be addressed to either of these authors (email k_kakehi@phar.kindai.ac.jp or tsuzuki_gm@riken.jp).
including free glycans into the cytosol. Consistent with this hypothesis, overexpression of the lysosomal sialidase Neu1 in MKN45 cells resulted in the dramatic reduction of complex-type free glycans, indicating that lysosomes were the primary source of the large amount of free sialoglycans. Interestingly, the overexpression of cytosolic sialidase Neu2 also resulted in the reduction of free sialoglycans, although not as dramatic as the case with Neu1. This result clearly showed that the lysosome-originated free sialoglycans were indeed leaked out to the cytosol, where the Neu2 enzyme was accessible. This result may also imply the occurrence of the degradation pathway for free complex-type glycans in the cytosol, although this 'non-lysosomal' degradation pathway for N-glycans has so far been overlooked.
MATERIALS AND METHODS

Materials
Sephadex LH-20 was obtained from Amersham Biosciences. The serotonin-immobilized column (4.6 mm × 250 mm), Amide-80 column (4.6 mm × 250 mm) and NH2P-50 column (4.6 mm × 250 mm) were from Seikagaku Kogyo (Chuo-ku, Tokyo, Japan), Tosoh (Minato-ku, Tokyo, Japan) and Showa Denko (Minatoku, Tokyo, Japan) respectively. Sodium cyanoborohydride and 2AA (2-aminobenzoic acid) for fluorescent labelling of oligosaccharides were from Tokyo Kasei Kogyo (Chuo-Ku, Tokyo, Japan). α-Mannosidase, β-galactosidase and β-N-acetylhexosaminidase were from jack beans, and obtained from Seikagaku Kogyo. Neuraminidase from Arthrobacter ureafaciens was donated by Dr Ohta of Marukin-Bio (Uji, Kyoto, Japan). Protease inhibitor cocktail for animal cells was obtained from Nakarai Tesque (Nakagyo-ku, Kyoto, Japan). Lectins from Maackia amurensis (MAM), Sambucus sieboldiana (SSA) and Phaseolus vulgalis (PHA-E4) were obtained from Seikagaku Kogyo. All other reagents were of the highest grade commercially available. All aqueous solutions were prepared using water purified with a Milli-Q purification system (Millipore, Bedford, MA, U.S.A.).
Cell culture
In the present study, we used the human-derived cancer cells AGS (gastric cancer cells), A549 (lung cancer cells), ACHN (kidney glandular cancer cells), CCRF-SB (lymphoblastic leukemia cells), Jurkat (T-cell leukemia cells), K562 (chronic leukemia cells), MKN7 (well-differentiated gastric cancer cells), MKN45 (poorly-differentiated gastric cancer cells), U937 (histiocytic lymphoma cells) and ZR75-1 (breast cancer cells). ACHN, AGS, ZR75-1 and A549 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10 % (v/v) fetal calf serum and puromycin (Sigma-Aldrich Japan, Minato-ku, Tokyo, Japan) at a final concentration of 0.375 μg/ml. Jurkat, K562, U937, CCRF-SB, MKN7 and MKN45 cells were cultured in RPMI 1640 medium supplemented with 10 % (v/v) fetal calf serum. Fetal calf serum was kept at 56
• C for 30 min before addition. The cells were cultured at 37
• C under 5 % CO 2 atmosphere and harvested at 80 % confluent state. Cells were washed with PBS and collected by centrifugation at 1000 g for 20 min.
Preparation of total free glycans in cancer cells
Free glycans were collected by modifying the method for collection of lipid fractions from biological samples [11, 12] . Briefly, after washing the cells with PBS several times, 1 × 10 7 cells were homogenized with a glass homogenizer for 3 min in 10 mM phosphate buffer (pH 7.3, 150 μl) containing 1 % protease inhibitor. The mixture was mixed vigorously with methanol (400 μl) and chloroform (200 μl) using a vortex mixer. After centrifugation of the mixture at 7000 g for 10 min, the supernatant (550 μl) was collected. Into the aqueous layer, methanol (900 μl) and chloroform (1500 μl) were added, and the mixture was again agitated with a vortex mixer. At this point, a clear solution was obtained. To the solution, water (900 μl) and chloroform (750 μl) were added. The emulsion was then centrifuged at 7000 g for 10 min, and the upper layer was collected and freeze-dried to dryness. The residue was used for the analysis of free glycan fractions.
Fluorescent labeling of free glycans with 2AA
The freeze-dried material described above was labelled with 2AA according to the method reported previously [13] . Briefly, to the freeze-dried material was added a solution (200 μl) of 2AA and sodium cyanoborohydride, freshly prepared by dissolution of both compounds (30 mg each) in methanol (1 ml) containing 4 % sodium acetate and 2 % boric acid. The mixture was kept at 80
• C for 1 h. After cooling, the solution was applied to a column of Sephadex LH-20 (1 cm × 30 cm) equilibrated with 50 % aqueous methanol. Earlier eluted fractions showing fluorescence at 410 nm with excitation at 335 nm were collected and evaporated to dryness. The residue was dissolved in water (100 μl), and one tenth was analysed by HPLC.
Group separation of oligosaccharides based on the number of bound sialic acid residues using serotonin-affinity chromatography Separation of the glycans was performed with a Jasco apparatus equipped with two PU-980 pumps and a Jasco FP-920 fluorescence detector. At the initial step, the mixture of fluorescently labelled free glycans in cancer cells obtained as described above was separated based on the number of bound sialic acid residues using a serotonin-immobilized column with a linear gradient from 100 % H 2 O (solvent A) to 40 mM ammonium acetate (solvent B) at a flow rate of 0.5 ml/min. Initially, solvent B was used at a 5 % concentration as eluent for 2 min, and then linear gradient elution was performed to 30 mM ammonium acetate for 35 min, and finally the eluent was changed to solvent B (40 mM ammonium acetate) during the following 10 min. Each peak was collected and freeze-dried to dryness.
It is important to separate free glycans based on the number of sialic acid residues prior to the separation by normal-phase HPLC (see below), because direct separation after digestion of a mixture of free oligosaccharides with neuraminidase makes it difficult to resolve the complex mixture of oligosaccharides by HPLC.
Preparation of asialo-glycans
After separation of free glycans based on the number of sialic acid residues as described above, each glycan fraction containing sialic acids was digested with neuraminidase [13] . Neuraminidase (2 munits, 4 μl) was added to the mixture of sialoglycans in 20 mM acetate buffer (pH 5.0, 20 μl), and the mixture was incubated at 37
• C overnight. After placing the mixture in the boiling water bath for 3 min followed by centrifugation, the supernatant was used for HPLC analysis.
HPLC of the asialo-glycans
The apparatus was the same as described for the analysis of sialic acid-containing oligosaccharides. Separation was performed with an Amide-80 column using a linear gradient formed by 0.1 % acetic acid in acetonitrile (solvent A) and 0.2 % acetic acid in water containing 0.2 % triethylamine (solvent B). The column was initially equilibrated and eluted with 70 % solvent A for 2 min. Then, solvent B was increased to 95 % over 80 min and kept at this composition for a further 100 min.
MALDI-TOF MS (matrix-assisted laser-desorption ionization-time-of-flight MS)
MALDI-TOF mass spectra of the labelled glycans were observed on a Voyager DE-PRO apparatus (PE Biosystems, Framingham, MA, U.S.A.). A nitrogen pulsed laser was used to irradiate samples at 334 nm, and an average of 50 shots was taken. The instrument was operated in linear mode using negative polarity at an accelerating voltage of 20 kV. Samples (approx. 10 pmol, 0.5 μl) were applied to a polished stainless steel target, to which was added a 2 % solution (0.5 μl) of DHB (2,5-dihydroxybenzoic acid) in a methanol/water (1:1, v/v) mixture. The mixture was dried in the atmosphere by keeping it at room temperature (25
• C) for several minutes. All MS/MS (tandem MS) spectra were acquired with a MALDI QIT (quadrupole ion trap) TOF mass spectrometer (AXIMA-QIT; Shimadzu, Kyoto, Japan). Acquisition and data processing were controlled by Launchpad software (Kratos Analytical, Manchester, U.K.). For collisioninduced dissociation, argon was used as the collision gas. For sample preparation, a 0.5 μl volume of the matrix solution (DHB; 10 mg/ml in 30 % ethanol/0.1 % trifluoroacetic acid) was deposited on the stainless steel target plate and allowed to dry. Then, a portion (0.5 μl) of the appropriately diluted analyte solution (approx. 1 pmol/μl) was used to cover the matrix on the target plate and allowed to dry. The MS/MS spectra of sialic acidcontaining glycans were observed after methylation of carboxylic acid residues according to the method reported previously [14] .
CAE (capillary affinity electrophoresis)
The linkage position of the NeuAc to the Gal residue was determined by CAE according to the method reported previously [15] . CAE was performed using a P/ACE MDQ glycoprotein system (Beckman Coulter, Minato-ku, Tokyo, Japan) equipped with an eCAP N-CHO capillary (20 cm effective length, 30 cm total length, 50 μm i.d., Beckman Coulter) using a He-Cd laser-induced fluorescence detector. Tris/acetate buffer (100 mM; pH 7.4) containing SSA or MAM at 0.5 μM concentrations was used as the electrolyte. The solution containing the sialoglycan was introduced to the capillary by pressure method [0.5 p.s.i. (1lbf/in 2 = 6.9 kPa)]. Separation was performed at 25
• C at the applied potential of 18 kV. Prior to CAE, a sample solution was analysed in the absence of lectin. Then, the same electrolyte containing SSA or MAM at 0.5 μM was added to the capillary, and the sample solution was analysed.
When NeuAc is attached to the 6-position of the Gal residue, the glycan peak disappears in the presence of SSA, but shows no change in the presence of MAM. When NeuAc is attached to the 3-position of the Gal residue, the glycan peak is changed dramatically in the presence of MAM. Thus, by observing difference in migrations in the presence and in the absence of the lectin, the linkage position of NeuAc to Gal can be easily determined.
Preparation of cytosol and lysosome fractions in MKN45 cells
Cytosol and lysosome fractions were prepared according to the method reported previously [16] . Cells (6.0 × 10 6 ) were harvested and suspended in 0.25 M sucrose in 3 mM Tris/HCl buffer (pH 7.4, 300 μl) containing 0.1 mM EDTA and homogenized using a glass homogenizer. The homogenate was centrifuged at 600 g for 5 min. The supernatant was centrifuged at 9000 g for 10 min, and the supernatant was collected and centrifuged further at 100 000 g for 1 h. The supernatant obtained was used as a cytosol fraction. The pellet obtained after centrifugation at 9000 g for 10 min was suspended in the same buffer and centrifuged again at 600 g for 5min. The supernatant was then centrifuged at 9000 g for 10 min, and the pellet was used as a lysosome fraction. Cytosol and lysosome fractions were confirmed by measuring marker enzymes as follows.
LDH (lactate dehydrogenase)
A portion (25 μl, corresponding to 5 × 10 5 cells) of each fraction was mixed with a substrate solution containing 150 mM lithium lactate and 7 mM NAD + in 50 mM Tris/HCl buffer (pH 7.6, 250 μl). A 4.5 μl portion of Nitro Blue in methanol (68 mg/ml) and a 5.0 μl portion of diaphorase (5 mg/ml) in 50 mM Tris/HCl buffer (pH 7.6) was added to the mixture. After incubation of the mixture at room temperature for 30 min, the reaction was stopped by the addition of 0.5 M HCl (100 μl), and the activity of LDH was observed by measuring the absorbance at 570 nm using a microplate reader (Model 550, Bio-Rad Laboratories).
β-N-Acetylhexosaminidase
A portion (50 μl, corresponding to 1 × 10 5 cells) of each fraction was mixed with 100 μl of 5 mM p-nitrophenyl N-acetyl-β-Dglucosaminide in 50 mM citrate buffer (pH 4.4). The mixture was incubated at 37
• C for 45 min. After addition of an aqueous solution (200 μl) of 250 mM Na 2 CO 3 , the activity of β-Nacetylhexosaminidase was observed by measuring the absorbance at 405 nm using the microplate reader.
Construction of plasmids and establishment of Neu1-or Neu2-overexpressing MKN45 cells (Neu1-MKN45 and Neu2-MKN45)
Human Neu1 ORF (open reading frame) was amplified from the EST (expressed sequence tag) clone no. 4863779 (Genbank ® No. BU601648) with the primers 5 -AAAAAGAATTCGCCACCA-TGACTGGGGAGCGACCCAGCACGGCGC-3 and 5 -AAA-AACTCGAGTGTCCCATAGACACTGA-3 . The PCR fragment was digested with EcoRI/XhoI and was cloned into pCMV-Tag4 (Stratagene) to generate the FLAG-epitope at the C-terminus in frame. The C-terminal tagging of Neu1 was previously used for functional studies of Neu1 protein [17] . For human Neu2 ORF, original pGEX4T-NEU2 plasmid [18] was provided by Dr. Soichi Wakatsuki [High Energy Accelerator Research Organization (KEK), Tsukuba, Japan]. The Neu2 ORF was PCR amplified with primers including restriction enzyme sites (5 -AAAAA-GGATCCATGGCGTCCCTTCCTGTCCT-3 and 5 -AAAAAG-AATTCTCACTGAGGCAGGTACTCAG-3 ). The PCR fragment was digested with BamHI/EcoRI and was cloned into pCMVTag2 (Stratagene) to generate the FLAG-epitope tag at the Nterminus in frame. The sequence was confirmed using an ABI Big Dye Terminator Sequencing mix and ABI PRISM 3100 genetic analyser. An MKN45 cell line stably expressing human Neu1 (Neu1-MKN45), or Neu2 (Neu2-MKN45) as well as a mock transfectant was established by limited dilution using the Lipofectamine TM reagent (Invitrogen) according to the manufacturer's protocol.
Western blotting
Expression of FLAG-Neu2 was confirmed by anti-FLAG antibody (M2) (Sigma). Preparation of cytosol from cells and detection of the protein were carried out as described previously [19, 20] . Distribution of lysosomal membrane protein was examined using anti-Lamp1 (lysosome-associated membrane protein 1) rabbit polyclonal antibody (Abcam) under conditions according to the manufacturer's instructions.
RT-PCR (reverse transcriptase-PCR)
Total RNA was prepared from MKN45 and Neu2-MKN45 cells using TRIzol Reagent (Invitrogen) according to the manufacturer's protocol. After digestion with DNaseI, total RNA was subjected to the single strand DNA synthesis with SuperScript III RT (Invitrogen) according to the manufacturer's protocol. PCR primers were selected to encompass the intron of Neu2 gene; the forward primer, CGGGCAAGCAAGAAGGAT, was located in the first exon, and the reverse primer, TGACCACGG-GAGGACCTG, was in the second exon; thus the amplification of contaminated genomic DNA fragment, whose product would be longer compared with the one of cDNA, was minimized. Prior to PCR amplification, the cDNA mixture was treated with ApaI to degrade the template in order to quench the non-specific signal supposedly from other genes, because Neu2 is expressed at a far lower level compared with other, more abundant, genes.
Sialidase assay
For the substrate, we used 4MU-NeuAc (4-methylumbelliferyl NeuAc) [21] . For the lysosomal sialidase assay, lysosome fractions (see above), in 0.1 M acetate buffer (pH 4.5, 100 μl), of the transfected cells (10 6 cells) were mixed with 0.1 mM 4MU-NeuAc in the same buffer (200 μl) and the mixture was incubated at 37
• C for 2 h. After stopping the reaction by addition of 0.25 M glycine buffer (pH 10.6, 0.8 ml), the fluorescence intensity was measured at 450 nm, with excitation at 365 nm. For the cytosolic sialidase assay, cytosol fractions in 0.2 % Triton X-100/50 mM sodium citrate buffer (pH 6.0, 100 μl) of the transfected cells (10 6 cells) were incubated with 0.1 mM 4 MU-NeuAc in the same buffer (200 μl) for 4 h at 37
• C. The procedures for the measurement of fluorescence were the same as those for lysosomal sialidase. One unit was defined as the amount required for catalysing the release of 1 nmol of 4MU from 4MU-NeuAc for 1 h.
RESULTS
Analysis of free glycans observed in MKN7 and MKN45 cells
At the initial step, free glycans accumulated in the ten human cancer-derived cell lines were analysed based on the number of the attached sialic acid residues. The glycan groups, having different numbers of sialic acid residues, were conveniently separated by affinity chromatography using a serotonin-immobilized column [10] . The amounts of accumulated free glycans in 2 × 10 6 cells for each cancer cell line were compared (Figure 1a) . Results on the separation of free glycans in two types of gastric cancer cell lines (MKN7 and MKN45) by serotonin-affinity chromatography are shown in Figure 1(b) . Cells derived from solid tumours such as A549, ACHN, ZR75-1 and AGS cells contained free glycans at easily detectable levels. In contrast, free glycans in U937, CCRF-SB, Jurkat and K562 cells were hardly detected when 2 × 10 6 cells were used for the analysis (Figure 1a) .
The most characteristic feature is that there were extremely large amounts of free glycans in MKN7 and MKN45 cells (Figure 1a) . Especially, free sialoglycans were present in MKN7 and MKN45 cells. The relative ratios of asialoglycans present in MKN45 and MKN7 cells were not high (6 % and 4 % respectively), as shown in the pie charts of Figure 1(b) . These Figure 1b ), the sums of the peak areas of mono-, di-, triand tetra-sialoglycans and asialo/high-mannose glycans are summarized. These results were obtained using 2 × 10 6 cells, prepared and injected into the HPLC. (b) Serotonin affinity chromatography of free glycans in MKN7 and MKN45 cells. The observed peaks were collected and used for further analysis by MALDI-TOF MS and structural studies. The two peaks observed at the mono-sialoglycan region between 5-10 min in the analysis of free glycans of MKN45 cells were collected separately, and designated as 1SA-1 and 1SA-2, respectively. Relative ratios of asialo-, mono-, di-, tri-and tetra-sialoglycans are shown in the pie charts.
results were quite different from those observed in the analysis of free glycans of other cancer cells. In particular, MKN45 cells showed two peaks of monosialoglycans, which reached 65 % of total glycans. Di-, tri-and tetra-sialoglycans were also observed abundantly, and total sialoglycans were approx. 94 %. MKN7 cells also contained large amounts of free sialoglycans (96 %). The relative abundances of mono-, di-, tri-and tetra-sialoglycans were 36 %, 28%, 20% and 12 % respectively.
Based on these preliminary studies, we carried out detailed structural analysis of the unusual free glycans in MKN7 and MKN45 cells. Each fraction in the analysis of free glycans in both MKN7 and MKN45 cells separated by serotonin-affinity chromatography (Figure 1b ) was collected and examined by MALDI-TOF MS (Figure 2 ). These fractions were also analysed by HPLC using an Amide-80 column as stationary phase after neuraminidase digestion (Figure 3 ). After collection of the peaks observed in Figure 3 , the glycans were also examined by MALDI-TOF MS. The list of observed molecular masses and proposed monosaccharide compositions is summarized in Table 1 . The amount of glycans present in each fraction is also included.
The fraction containing asialo/neutral glycans obtained from MKN45 cells (Figure 1b) showed typical patterns for high-mannose type glycans by HPLC analysis (Figure 3) . From the data obtained by MALDI-TOF MS, these high-mannose type glycans (peaks 1-5) commonly contained only one HexNAc (i.e. GlcNAc) residue (Table 1 ). MKN7 cells also contained high-mannose type glycans (peaks 1-5), but glycans having asialo-biantennary structures (peaks 6-8), calculated from their monosaccharide compositions, were also found as minor glycans. The glycan at peak 6 is Hex 5 dHexHexNAc 3 -2AA. The occurrence of a Lewis X structure in this glycan was suggested by CAE analysis using RSL (Rhizopus stolonifer lectin) (results not shown) [22, 23] . Therefore, the structures predicted for peak 6 were Galβ1-4( + − Fucα1-3)GlcNAcβ1-4Manα1-6(Galβ1-4( + − Fucα1-3)GlcNAcβ1-4Manα1-3)Manβ1-4 GlcNAc-2AA. At present, it is not clear which branch bears the fucose residue due to the minute amount of peak 6. The glycan at peak 7 contained an additional GlcNAc residue, although a fucose residue was not present. This indicates that glycan (7) is a biantennary glycan having a bisecting GlcNAc residue. The glycan at peak 8 contained a fucose residue on the glycan (7).
Monosialo-glycan fractions derived from MKN45 cells gave an abundant peak 9 as well as peak 10, along with a small peak 11 ( Figure 3) . We confirmed the structure of peak 9 in Figure 3 , showing a molecular ion at m/z 1031.8 (Table 1) , which had been observed at m/z 1323.0 before neuraminidase treatment. In the present study, we performed methyl esterification of the sialylated peak 9 prior to MS/MS analysis to observe the fragment ions of sialo-glycan as stable ions [14] . The methyl esterified product of the sialylated peak 9 showed a sodium ion adduct at m/z
Figure 3 Analysis of glycans present in MKN7 and MKN45 cells after neuraminidase digestion
After total glycans in MKN7 and MKN45 cells were separated by serotonin affinity chromatography (Figure 1b) , fractions containing sialo-glycans (1SA, 2SA, 3SA and 4SA) were digested with neuraminidase from A. ureafaciens. The asialo-glycans thus obtained were analysed by HPLC using an Amide-80 column as stationary phase, as described in the Materials and methods section. The peaks observed in each chromatogram were collected and analysed by MALDI-TOF MS. The MS data are summarized in Table 1 . (Figure 4a ). Characteristic fragment ions of both Y and B series were clearly observed, and monosaccharide sequence was assigned as shown in the upper panel of Figure 4 (a). The structure of the sialylated peak 9 was studied further by digestion with specific exo-glycosidases (Figure 4c ). Digestion with neuraminidase, which cleaves α2,3,6,8-linkages of NeuAc, gave a glycan of Hex 3 HexNAc 2 structure. Digestion of the asialo-glycan with β-galactosidase followed by digestion with β-N-acetylhexosaminidase gave a trisaccharide of Hex 2 HexNAc structure. α1,6-Mannosidase from bovine kidney did not act on this trisaccharide, but the jack bean enzyme, having wider specificity, cleaved a mannose residue to give a disaccharide of HexHexNAc structure. The linkage between NeuAc and Gal was confirmed by CAE using MAM and SSA (Figure 4d ) [15] . MAM and SSA recognize NeuAcα2-3 and NeuAcα2-6 linkages, respectively. In the presence of MAM at 0.5 μM concentration, the migration time of peak 9 was not changed. In contrast, peak 9 completely disappeared in the presence of SSA at 0.5 μM concentration. These results clearly indicate that the glycan peak 9 has the structure of NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3Manβ1-4GlcNAc. As shown in Figure 3 , the monosialoglycan fraction (1SA) of MKN45 cells contained two glycans (peaks 10 and 11) other than peak 9. The Table 1 Free glycans present in MKN45 and MKN7 cells
1373.6, and was analysed by MS/MS
The molecular masses of the glycans were observed by MALDI-TOF MS after isolation by HPLC (see Figure 3) . The cell data were obtained in three independent experiments and are expressed as means + − S.D. Sialoglycans were converted into asialo-glycans, and they were separated by HPLC (see Figure 3) . The values in parentheses are the molecular masses as sialoglycans. The observed molecular masses are recorded in bold face.
* The glycans from peaks 6 and 7 and peaks 29 and 30 were not separable under the HPLC conditions used, and therefore the combined amount is presented. A dash indicates that this glycan was not detected in the cell type. sialylated glycan of peak 10 showed a molecular ion at m/z 1486.9, which was assigned as NeuAcHex 4 HexNAc 2 -2AA. In a similar manner to the structural analysis of the sialylated peak 9, carboxyl groups of NeuAc and 2AA residues were also methyl esterified, and analysed by MS/MS (Figure 4b ). The fragment ion (Y 3β ) observed at m/z 865.3 indicates the presence of a core structure [Manα1-6(Manα1-3)Manβ1-4GlcNAc]. Accordingly, the structure of peak 10 was assigned as NeuAcα2-6Galβ1-4GlcNAc β1-2Manα1-3(Manα1-6)Manβ1-4GlcNAc. In addition, the small peak 11 observed at m/z 1686 was due to NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAc (reults not shown). From the structures of these glycans, we found that the branch at the Manα1-6 side of disialobiantennary glycan was preferentially trimmed in MKN45 cells. MKN7 cells, well-differentiated stomach cancer cells, also contained the free monosialo-glycans which were observed in MKN45 cells. From their molecular masses observed by MALDI-TOF MS, monosaccharide compositions are also given in Table 1 . We found some characteristic free glycans (peaks [12] [13] [14] [15] , and also di-, tri-and tetra-sialoglycans. Glycans having bisecting GlcNAc structure (peaks 12, 14 and 20) were confirmed by CAE after neuraminidase digestion using PHA-E4, which specifically recognizes the bisecting GlcNAc residue [22] . In the presence of PHA-E4 at 10 μM concentration, these peaks disappeared completely (results not shown). Interestingly, we also detected many fucose-containing free glycans (peaks 6, 8, 13, 14, 17, 19, 22, 26, 28, 29 and 30) , although they were present as minor glycans. Fucose residue(s) are predicted to be located at the peripheral lactosamine residue(s) to form a Lewis X structure based on the studies of their association with RSL lectin by CAE [23] , as indicated in glycan peak 6 in MKN45 cells.
Localization of free glycans in MKN45 cells
Our method for isolation of free glycans by phase-split method was found to be an easy reliable one which was highly reproducible. However, since cells were directly subjected to chloroform/ methanol treatment, the subcellular origin of these glycans was not clear. Therefore, cytosol and lysosome fractions from MKN45 cells were prepared to determine the subcellular localization of free glycans. We selected Jurkat cells as a control because Jurkat cells accumulated typical high-mannose type glycans, although the amount was not high (Figure 1a) . The activities of marker enzymes (i.e. LDH and β-N-acetylhexosaminidase for cytosol and lysosome respectively) in each fraction were determined + . (c) Sequential digestion of the sialylated glycan peak 9 with specific enzymes. (d) CAE of the sialylated peak 9 in the presence of sialic acid-specific lectins. The peak observed at approx. 12 min was due to isomaltopentaose labelled with 2AA (G5-2AA), which was used as internal marker for migration times. The migration time of G5-2AA was not changed in the presence or absence of MAM or SSA.
( Figure 5a ). As shown in this Figure, in Jurkat cells, LDH activity was predominantly observed in the cytosolic fraction, and β-hexosaminidase activity was found in the lysosome fraction. In sharp contrast, MKN45 cells exhibited significant lysosomal enzyme activity (i.e. β-hexosaminidase) in cytosolic fractions, raising the possibility that the integrity of lysosomal membranes was somewhat compromised in MKN45 cells.
On the basis of these observations, we determined the subcellular localization of free glycans in both cell lines. In the Jurkat reference cells, we found typical chromatographic patterns of high-mannose type glycans in cytosol fractions in the elution times between 17-27 min by HPLC using a Tosoh Amide-80 column, which shows good resolution in the analysis of neutral glycans. However, free glycans were not detected in lysosome fractions in Jurkat cells (Figure 5b) . Interestingly, MKN45 cells, in sharp contrast with the case observed in Jurkat cells, contained free glycans in both cytosolic and lysosome fractions. It should be noted that neutral glycans (observed between 15-30 min) were detected abundantly in cytosolic fractions, but the complex-type sialoglycans (observed between 35-60 min) were recovered from both cytosolic and lysosome fractions (Figure 5c ). The amount of sialoglycans found in cytosolic fractions was approximately three times higher than that in lysosome fractions. High mannose-type free glycans are most likely generated through the ERAD pathway (i.e. released directly into the cytosol) or alternatively released from the dolichol-PP-OS by an uncharacterized mechanism, which is quickly released into the cytosol. On the other hand, sialoglycans may be derived from the lysosome due to the leakage of lysosomal lumenal components into the cytosol.
To confirm further the origin of the sialo-glycans, lysosomal sialidase (Neu1) was stably expressed in MKN45 cells (Neu1-MKN45 cells). The lysosomal activity was greatly upregulated by the stable expression of Neu1-FLAG protein (Figure 6a ). Then we isolated the free oligosaccharides accumulated in Neu1-MKN45 cells by the phase-split method and the results were quantitatively compared with those of MKN45 control cells. As shown in Table 2 , there was a striking reduction in the amount of sialoglycans with expression of lysosomal Neu1, where virtually no sialoglycans were detected. These results strongly suggested the lysosomal origin of these glycans. In sharp contrast, high mannose-type glycans were still observed in these cells. The sum of the major high mannose-type glycans (Hex 5 HexNAc-2AA and Hex 6 HexNAc-2AA) was approx. 30 pmol/10 6 cells, which was lower than but comparable with those (approx. 80 pmol) found in MKN45 cells.
Besides lysosomal Neu1, so far three other types of sialidases have been characterized from mammalian sources, and are Consistent with this result, cytosolic sialidase activity was only detected in Neu2-MKN45, whereas in MKN45 cells the activity was not detected above the background level under the assay conditions used (Figure 6b ). These results collectively showed that Neu2 protein is absent in MKN45 cells, but is expressed in the cytosol of Neu2-MKN45 cells. We then compared the free oligosaccharides recovered in Neu2-MKN45 cells with those in MKN45 cells (Table 2) . Interestingly, the accumulation of sialylated free glycans was greatly reduced in Neu2-MKN45 cells, although not as drastic as the case with Neu1-MKN45 cells. These results indicated that these glycans were indeed localized in the cytosol, most likely by the leakage from the fragile lysosomes, and that sialidase action was a rate-limiting step for the catabolism of these complex-type free N-glycans.
DISCUSSION
In the present study, we discovered accumulation of complex-type free glycans in the cytosol of MKN7 and MKN45 (Table 1) . From the combination of studies using MS/MS, CAE and sequential digestions with specific glycosidases after collection of these glycans by HPLC, we found that the Manα1-6 arm was specifically removed from the biantennary glycan to form a characteristic glycan, NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3Manβ1-4GlcNAc (Figure 4 ). Such glycan structure was often observed in fibroblasts and leucocytes and an excessive urinary excretion of sialoglycans in sialidosis and I-cell disease [29] [30] [31] . Given the structural similarity of free glycans in MKN7 and MKN45 cells with those from sialidosis/galactosialidosis patients, we hypothesized that the free glycans were derived from the lysosomes. Supporting this hypothesis, MKN45 cells contained sialo-glycans with fucose residues at multiple sites when total N-glycans on membrane glycoproteins were analysed [10] , while no Fuc-containing free glycans were observed in this cell line (Table 1) . Since neutral α-fucosidase was not detected in the cytosol fraction (results not shown), we can assume that removal of fucose residue(s) should occur at the lysosomal compartment. On the basis of the glycan structures accumulated in the cytosol, it is likely that MKN45 has a compromised lysosomal sialidase activity, while lysosomal fucosidase activity seems unimpaired, as exemplified by the lack of fucosylated free glycans. However, MKN7 cells had a more pronounced effect on lysosomal function and even fucosidase digestion was not completed as evidenced by the occurrence of fucosylated free glycans (Table 1) .
Since the first finding of the presence of free sialoglycans in eggs of freshwater trout (Plecoglossus altivelis) [32] , a family of typical complex-type glycans was reported in various unfertilized eggs and embryos of fish [33, 34] . Similar free glycans are also formed in hen's egg yolk, and originated from lysosomes [35] . However, it has not been unequivocally shown whether such complex-type glycans do exist in large quantities in the cytosol of animal cells and this is the first report on accumulation of large amounts of complex-type free N-glycans in the cytosol of mammalian cells. Interestingly, characteristic glycans such as NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3Manβ1-4GlcNAc were detected only in some of the human stomach cancer cells among various cancer-derived cell lines. These results raise a possibility that occurrence of such glycans can be regarded as biomarker for certain specific cancers. In this connection, it is interesting to note that a recent report has shown that glucosylated free N-glycans are accumulated in cells as well as in urine upon α-glucosidase inhibition, and these accumulated glycans can serve as biomarkers of a certain pathological condition which causes ER glucosidase inhibition [36] .
To get more insight into the origin of these unusual free sialoglycans, subcellular localization of free glycans in MKN45 cells was determined, and we found that two thirds of glycans were present in the cytosolic fraction and one third was in lysosome (membrane) fractions. Interestingly, high-mannose type glycans were exclusively present in cytosol fractions, strongly suggesting that the sources of high-mannose type free glycans and those of complex type were distinct. As indicated in Figure 5 , notable leakage of lysosomal components was observed in MKN45 cells. No such leakage was observed in Jurkat cells, which do not contain free sialoglycans in the cytosol. These results indicate that the lysosomal membrane in MKN45 cells is relatively fragile and therefore the lysosomal functions are significantly compromised. As a result, lysosomal enzymes as well as accumulated glycans were also observed in cytosolic fractions.
Neuraminidase is capable of releasing sialic acids from different sialoglycoconjugates, and four isoenzymes are present in mammals. These isoenzymes have been characterized by distinct genes, molecular features and subcellular localization, and are designated as Neu1, Neu2, Neu3 and Neu4 [26] . Our results clearly showed that the overexpression of lysosomal Neu1 enzyme resulted in almost complete loss of free sialoglycans. The results also support our hypothesis that these free sialoglycans in MKN45 cells are actually lysosomal in origin. On the other hand, Neu2 is a cytosolic enzyme, and acts on various sialoglycans such as sialyl-lactose, 4-methylumbelliferyl N-acetylneuraminic acid, gangliosides and sialoglycoproteins. Although this enzyme has been suggested to be involved in various cell signalling events [37] [38] [39] , detailed mechanism by which such signals are mediated has still been elusive due to lack of detailed information on its physiological substrates [40, 41] . We assume that the free sialoglycans found in the cytosol of MKN7 or MKN45 cells can be easily accessible to the cytosolic Neu2 protein, and therefore these glycans are physiological targets of this enzyme. Our results clearly showed the striking reduction of sialoglycans in Neu2-MKN45 cells, although not as dramatic as the case with Neu1. This result clearly indicates that (a) free sialoglycans are indeed localized in the cytosol and (b) Neu2 action is the rate-limiting step for processing of free sialoglycans in the cytosol. The molecular mechanism of a 'non-lysosomal', cytosolic degradation pathway for free oligosaccharides is being uncovered for high mannose-type glycans [4, 20, 42] . Whether the equivalent degradation machinery for Golgi-type (i.e. complextype) glycans does exist in the cytosol is not understood. This is a very important question, because in mammalian cells, unlike the case with yeast cells where the glycans remain 'high mannose-type' throughout the secretory pathway, processing is achieved via drastic reorganization of glycan structure during vesicular transport. In catabolism of complex-type sialoglycans in the cytosol, many additional glycosidases such as sialidase, galactosidase and hexosaminidase should exist. It should be noted that various neutral glycosidase activities have been biochemically isolated in the soluble (cytosolic) fraction [43] [44] [45] [46] [47] . It would be interesting to examine if these glycosidases are involved in the degradation of free sialoglycans formed in the cytosol as well. For instance, cytosolic hexosaminidase is now known to be involved in the removal of O-GlcNAc residues [44] , but this enzyme is also capable of cleaving the GlcNAcβ1-6Man linkage [48] . Although the mechanism of the generation of complex-type free glycans is not fully understood, glycans formed in lysosomes of MKN45 cells leaked into the cytosol through the fragile membrane of lysosomes. Consistent with this idea, we observed that lysosomal components in MKN45 cells were also prone to leak out into the cytosol, as examined by the assay of β-hexosaminidase.
An alternative possible mechanism for generation of complextype oligosaccharides is through the ERAD as substrates that have travelled through the Golgi apparatus. Although such possibility is unlikely in MKN45 cells, we still have to take this into account under certain conditions for the following reasons: (i) it has been suggested that some ERAD substrates require the transport of proteins between ER and Golgi apparatus for their degradation [49] [50] [51] , implying the possible conversion of high mannose-into complex-type glycan may occur on N-glycans of such ERAD substrates; (ii) a recent study using Caenorhabditis elegans has indicated that free oligosaccharides in this organism are generated through ER-Golgi traffic [24] . Indeed, occurrence of such complex-type, biantennary glycans has been observed in mouse liver [9] . Whatever are the sources, we have shown that free sialoglycans are accumulated in the cytosol under specific conditions. Further efforts should be directed to uncover the metabolic pathway for such cytosolic complex-type glycans. At least a part of this 'non-lysosomal' degradation pathway should occur in the cytosol, and our results clearly showed that Neu2, a cytosolic sialidase, is involved in this process. Not only Neu2 but other cytosolic glycosidases may also be involved in the degradation of such 'complex' glycans. We believe that MKN7 and MKN45 cells are good targets to clarify the novel catabolic pathway.
